Prevymis (letermovir) - Merck (MSD)
Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients (clinicaltrials.gov) - Jun 12, 2026 - P3 | N=90 | Recruiting | Sponsor: University of Wisconsin, Madison | Trial completion date: Sep 2026 ➔ Aug 2027 | Trial primary completion date: Sep 2026 ➔ Aug 2027 
Trial completion date • Trial primary completion date • Cytomegalovirus Infection • Infectious Disease • Transplantation
http://clinicaltrials.gov/ct2/show/NCT06407232
 
Jun 12, 2026
 
Prev Next